TD SYNNEX to Announce Third Quarter Fiscal 2023 Results on September 26, 2023
FREMONT, Calif. & CLEARWATER, Fla.–(BUSINESS WIRE)–TD SYNNEX (NYSE: SNX) today announced it will report its…
FREMONT, Calif. & CLEARWATER, Fla.–(BUSINESS WIRE)–TD SYNNEX (NYSE: SNX) today announced it will report its…
GLENDALE, Calif.–(BUSINESS WIRE)–Public Storage (NYSE:PSA) announced today the launch of the Savvy Storage Insurance Program®…
Nucleome Therapeutics appoints Dr Russell Greig as Non–Executive Chair of the Board Dr Greig brings…
Nucleome Therapeutics appoints Dr Russell Greig as Non–Executive Chair of the Board Dr Greig brings…
VALNEVA Declaration of shares and voting rightsAugust 31, 2023__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue…
Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel,…
VALNEVA Declaration of shares and voting rightsAugust 31, 2023__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue…
Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel,…
TURKU, Finland and BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
TURKU, Finland and BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First…
After nearly seven years at Novartis and more than four years as a member of…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
After nearly seven years at Novartis and more than four years as a member of…
Geneva, Switzerland, September 6, 2023 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical…
Ad hoc announcement pursuant to Art. 53 LR Aprocitentan, Idorsia’s oral, dual endothelin receptor antagonist…
Significant improvement towards profitability year over year Revenues from customers spending $5,000 or more grew…
OxyTap Pte Ltd launches OxyTap 5, a regenerative oxygen supplement infuser that increases oxygen levels…
New York, New York–(Newsfile Corp. – September 6, 2023) – Dime, the pioneering Gen Z…
Toyota City, Japan, Sep 6, 2023 – (JCN Newswire) – Toyota Motor Corporation (Toyota) unveiled…